Immune Phenotypes of Nasopharyngeal Cancer.

CD207 CD8 cancer immune phenotype quantification survival

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
18 Nov 2020
Historique:
received: 17 10 2020
revised: 16 11 2020
accepted: 16 11 2020
entrez: 21 11 2020
pubmed: 22 11 2020
medline: 22 11 2020
Statut: epublish

Résumé

Nasopharyngeal cancer (NPC) features intralesional immune cells, but data are lacking on presence/distribution of T-cells and dendritic cells (DCs). Based on intralesional distribution of lymphocytes, a series of NPC biopsies (

Identifiants

pubmed: 33218184
pii: cancers12113428
doi: 10.3390/cancers12113428
pmc: PMC7699205
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : SKÅNE COUNTY COUNCIL
ID : n/a
Organisme : LUND UNIVERSITY
ID : n/a
Organisme : ACTA OTO-LARYNGOLOGICA FOUNDATION
ID : n/a
Organisme : LARYNGFONDEN
ID : n/a
Organisme : HENNING & IDA PERSSON'S RESEARCH FOUNDATION
ID : n/a
Organisme : EUROPEAN COMMUNITY´S HORIZON 2020 FRAMEWORK PROGRAMME FOR RESEARCH AND INNOVATION
ID : EU-H2020-MSCA-COFUND-2016-754299
Organisme : BERTA KAMPARD'S RESEARCH FOUNDATION
ID : n/a

Références

Nat Biotechnol. 2019 Jul;37(7):773-782
pubmed: 31061481
J Exp Med. 1998 Dec 7;188(11):2083-90
pubmed: 9841922
J Clin Invest. 2017 Aug 1;127(8):2930-2940
pubmed: 28650338
J Clin Pathol. 1984 Nov;37(11):1235-8
pubmed: 6389603
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
Front Immunol. 2016 May 25;7:197
pubmed: 27252701
Sci Rep. 2019 Oct 28;9(1):15432
pubmed: 31659192
Nature. 2014 Nov 27;515(7528):568-71
pubmed: 25428505
Oncol Lett. 2019 Feb;17(2):2557-2561
pubmed: 30719121
Int J Cancer. 2018 Jun 15;142(12):2558-2566
pubmed: 29377121
Cell. 2017 Dec 14;171(7):1611-1624.e24
pubmed: 29198524
Nature. 2017 Jan 18;541(7637):321-330
pubmed: 28102259
Oncogene. 2005 Sep 22;24(42):6367-75
pubmed: 16007187
Int J Cancer. 1984 Jun 15;33(6):813-9
pubmed: 6329970
In Vivo. 1995 May-Jun;9(3):225-9
pubmed: 8562888
Cell Mol Immunol. 2017 Apr;14(4):360-370
pubmed: 26456691
Int J Cancer. 2011 May 15;128(10):2501-8
pubmed: 20715107
Cell Res. 2020 Nov;30(11):1024-1042
pubmed: 32686767
Immunol Cell Biol. 2015 Jul;93(6):581-90
pubmed: 25643613
Nature. 2014 Nov 27;515(7528):563-7
pubmed: 25428504
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2216-25
pubmed: 17119049
Mod Pathol. 2017 Jan;30(s1):S68-S83
pubmed: 28060369
Jpn J Cancer Res. 1993 Aug;84(8):900-5
pubmed: 8407554
Hum Pathol. 1986 Sep;17(9):894-905
pubmed: 3759074
J Immunol. 2015 Aug 15;195(4):1763-73
pubmed: 26170391
Cancer Res. 2006 Aug 15;66(16):7999-8006
pubmed: 16912175
Adv Immunol. 1989;44:265-311
pubmed: 2493728
Sci Rep. 2018 May 23;8(1):8030
pubmed: 29795118
Oncogene. 2010 Feb 25;29(8):1093-102
pubmed: 19946335
J Immunother Cancer. 2019 Nov 13;7(1):298
pubmed: 31722750

Auteurs

Johan S Nilsson (JS)

Department of ORL, Head & Neck Surgery, Skåne University Hospital, 221 85 Lund, Sweden.
Department of Clinical Sciences, Lund University, 221 85 Lund, Sweden.

Aastha Sobti (A)

Department of Immunotechnology, Lund University, 223 81 Lund, Sweden.

Sabine Swoboda (S)

Department of ORL, Head & Neck Surgery, Skåne University Hospital, 221 85 Lund, Sweden.
Department of Clinical Sciences, Lund University, 221 85 Lund, Sweden.

Jonas S Erjefält (JS)

Department of Experimental Medicine, Lund University, 221 84 Lund, Sweden.

Ola Forslund (O)

Department of Microbiology, Lund University, 221 85 Lund, Sweden.

Malin Lindstedt (M)

Department of Immunotechnology, Lund University, 223 81 Lund, Sweden.

Lennart Greiff (L)

Department of ORL, Head & Neck Surgery, Skåne University Hospital, 221 85 Lund, Sweden.
Department of Clinical Sciences, Lund University, 221 85 Lund, Sweden.

Classifications MeSH